Story code: ST-000312
Part 3: Target Demographics
The damp cold of the alley asphalt seeped through my jeans, warring with the feverish heat radiating from my own blood. I stared at the silver pen Marcus thrust toward my face, the metal gleaming under the sickly amber glow of the streetlamp overhead. My chest heaved violently. My body was desperately trying to expel the toxic acid building up inside me, forcing me into a relentless, panting rhythm that felt like I was drowning in open air.
“Sign it, Leo,” Marcus repeated, his voice dropping the polished, affable tone he had used in the restaurant. He checked the heavy metallic watch on his wrist, a nervous tick betraying his calm facade. “I already have the car waiting. I’ll take you straight to the emergency room. You’ll get your fluids, your potassium, your insulin. Just put your name on the line.”
My hands shook so violently I could barely lift them. The crushed plastic of my insulin pen still clung to my left palm, the sickening smell of m-cresol filling my nostrils-a pungent, chemical reminder of exactly what I was losing. I reached out with my right hand, my fingers numb and clumsy, and took the heavy document from him.
I rested the thick paper against my bent knee. I needed to just sign it. I needed to live. If Marcus had sold our buggy software to Omni-Logistics to patch their gig-app data breaches, as my blurry vision had led me to believe inside, I could fight him in court later. I just needed an IV drip before my heart gave out.
But as I flattened the curled edges of the paper, the stark yellow light from the streetlamp illuminated the top corner of the page. My eyes, though swimming with exhaustion and glucose toxicity, finally locked onto the corporate crest.
It wasn’t the square, brutalist logo of Omni-Logistics I thought I had seen through the hazy blur inside the restaurant. It was a sharp, stylized blue ‘A’ intersecting with a double-helix.
Axon Pharma.
A fresh wave of nausea hit me, so intense my vision went entirely black for a fraction of a second. Axon Pharma. The pharmaceutical conglomerate that had bought the patent for my short-acting insulin six months ago and quietly quadrupled the retail price overnight. They were the sole reason I was driving twelve hours a day for gig apps. They were the reason I was rationing drops, the reason my body was eating its own organs in this freezing alley.
I dragged my heavy eyes down the page, squinting past the legal jargon, reading the bold headings that I had misinterpreted in my panicked, delirious state inside the steakhouse.
It didn’t say *Assumption of Legal Indemnity*.
It read: *Schedule B: Complete Transfer of Backend Analytics and User Demographics*.
And right beneath that, under a section detailing the transfer of funds, was Marcus’s name. *Marcus Vance: Vice President of Targeted Acquisitions, Axon Pharma.*
“What is this?” I rasped, the words tearing like sandpaper against my parched throat.
“It’s our exit strategy,” Marcus said quickly, taking a step closer, casting a long, dark shadow over me. “The venture capital well dried up, Leo. Nobody wanted to fund a nonprofit-model app for uninsured diabetics. The monetization wasn’t there. But the data? The user profiles? That’s gold.”
My brain struggled to process the sheer scale of the betrayal through the thick, toxic fog of ketoacidosis. For eight months, I had sat in my cramped bedroom, coding the encryption protocols for our affordable-meds app, Aegis Health. We had built a secure, peer-to-peer network designed to help desperate, underinsured patients pool their resources, track down grey-market medical supplies, and share crowdfunded insulin. We had eighty thousand users in the beta test. Eighty thousand terrified, vulnerable people who trusted us with their medical histories, their financial struggles, and their exact locations.
“You didn’t pitch this to VC firms,” I wheezed, my lungs burning as I forced the air out. “You pitched it to Axon.”
Marcus shifted his weight, his Italian leather shoes scraping against the wet pavement. “I got us a seat at the table, Leo! Axon is trying to map the uninsured demographic. They want to know exactly where the demand is highest so they can adjust their regional pricing models. Our backend gives them a perfect heat map of every desperate diabetic in the country.”
“You sold… our users,” I choked out, a horrifying realization locking my joints. “To the people… price-gouging them.”
“I secured a five-million-dollar buyout and a VP title!” Marcus snapped, his polished veneer finally cracking, revealing the raw, defensive panic underneath. “You think I want to spend the rest of my life begging for ten dollars in gas money? You think I want to be like you, starving to death over some moral high ground? I saved us. You’re getting a massive payout.”
“You gave them… a target list,” I whispered, clutching the document so hard the paper tore under my fingernails.
I looked up at him, my vision tunneling, the edges of the alley bleeding into darkness. The bespoke navy suit. The four-hundred-dollar wine. The thick envelope of crisp hundred-dollar bills. It was all blood money. Paid for by the exact same corporation that had pushed my own body to the brink of organ failure. Marcus hadn’t pivoted our business; he had used my illness, my passion for the community, to farm eighty thousand victims for a pharmaceutical cartel.
“Leo, you are going into a coma,” Marcus said, his voice rising in volume, echoing off the brick walls. He crouched down, grabbing my shoulder. “You are literally dying right in front of me. Stop being a martyr. Give me the signature, and I will call the ambulance. I swear to God. Just sign the damn paper.”
I looked down at the silver pen in my hand. I looked at the signature line waiting to authorize the slaughter of thousands of people just like me. Then I looked Marcus dead in the eyes, watching the desperate, greedy certainty in his expression slowly begin to curdle as I let the silver pen slip from my trembling fingers, listening to it clatter loudly away into the dark storm drain grate behind me.